Literature DB >> 25437282

Genetics, environment, and gene-environment interactions in the development of systemic rheumatic diseases.

Jeffrey A Sparks1, Karen H Costenbader2.   

Abstract

Rheumatic diseases offer distinct challenges to researchers because of heterogeneity in disease phenotypes, low disease incidence, and geographic variation in genetic and environmental factors. Emerging research areas, including epigenetics, metabolomics, and the microbiome, may provide additional links between genetic and environmental risk factors in the pathogenesis of rheumatic disease. This article reviews the methods used to establish genetic and environmental risk factors and studies gene-environment interactions in rheumatic diseases, and provides specific examples of successes and challenges in identifying gene-environment interactions in rheumatoid arthritis, systemic lupus erythematosus, and ankylosing spondylitis. Emerging research strategies and future challenges are discussed.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ankylosing spondylitis; Environment; Genetics; Interaction; Rheumatoid arthritis; Smoking; Systemic lupus erythematosus

Mesh:

Substances:

Year:  2014        PMID: 25437282      PMCID: PMC4250576          DOI: 10.1016/j.rdc.2014.07.005

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  136 in total

Review 1.  The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis.

Authors:  P K Gregersen; J Silver; R J Winchester
Journal:  Arthritis Rheum       Date:  1987-11

Review 2.  Role of enterobacteria and HLA-B27 in spondyloarthropathies: studies with transgenic mice.

Authors:  C L Nickerson; H S Luthra; C S David
Journal:  Ann Rheum Dis       Date:  1990-06       Impact factor: 19.103

3.  High association of an HL-A antigen, W27, with ankylosing spondylitis.

Authors:  L Schlosstein; P I Terasaki; R Bluestone; C M Pearson
Journal:  N Engl J Med       Date:  1973-04-05       Impact factor: 91.245

4.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

5.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

6.  Lifestyle and the risk of rheumatoid arthritis: cigarette smoking and alcohol consumption.

Authors:  J M Hazes; B A Dijkmans; J P Vandenbroucke; R R de Vries; A Cats
Journal:  Ann Rheum Dis       Date:  1990-12       Impact factor: 19.103

7.  Oral contraceptives, cigarette smoking and other factors in relation to arthritis.

Authors:  M P Vessey; L Villard-Mackintosh; D Yeates
Journal:  Contraception       Date:  1987-05       Impact factor: 3.375

8.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

Review 9.  What precedes development of rheumatoid arthritis?

Authors:  L Klareskog; L Alfredsson; S Rantapää-Dahlqvist; E Berglin; P Stolt; L Padyukov
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

10.  Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis.

Authors:  Karen H Costenbader; Daniel J Kim; Jehanna Peerzada; Shahin Lockman; Dolores Nobles-Knight; Michelle Petri; Elizabeth W Karlson
Journal:  Arthritis Rheum       Date:  2004-03
View more
  31 in total

Review 1.  Treatment failure in inflammatory arthritis: time to think about syndemics?

Authors:  Elena Nikiphorou; Heidi Lempp; Brandon A Kohrt
Journal:  Rheumatology (Oxford)       Date:  2019-09-01       Impact factor: 7.580

Review 2.  Advances in use of immunomodulatory agents--a rheumatology perspective.

Authors:  Minyoung Her; Arthur Kavanaugh
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-04-21       Impact factor: 46.802

3.  [The microbiome in rheumatic diseases : Driving force or confusing factor?]

Authors:  U Müller-Ladner
Journal:  Z Rheumatol       Date:  2016-11       Impact factor: 1.372

Review 4.  The role of gut microbiota in the pathogenesis of rheumatic diseases.

Authors:  Danli Zhong; Chanyuan Wu; Xiaofeng Zeng; Qian Wang
Journal:  Clin Rheumatol       Date:  2017-09-15       Impact factor: 2.980

5.  Protective effect of taraxasterol against rheumatoid arthritis by the modulation of inflammatory responses in mice.

Authors:  Shu-Hua Jiang; Li-Feng Ping; Feng-Yan Sun; Xiao-Lei Wang; Zhi-Juan Sun
Journal:  Exp Ther Med       Date:  2016-11-02       Impact factor: 2.447

6.  Epigenetics in systemic lupus erythematosus.

Authors:  Gong Xiao; Xiaoxia Zuo
Journal:  Biomed Rep       Date:  2015-12-11

Review 7.  The Roles of Cigarette Smoking and the Lung in the Transitions Between Phases of Preclinical Rheumatoid Arthritis.

Authors:  Jeffrey A Sparks; Elizabeth W Karlson
Journal:  Curr Rheumatol Rep       Date:  2016-03       Impact factor: 4.592

8.  Genetic polymorphism directs IL-6 expression in fibroblasts but not selected other cell types.

Authors:  Erika H Noss; Hung N Nguyen; Sook Kyung Chang; Gerald F M Watts; Michael B Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-17       Impact factor: 11.205

9.  ABO blood groups and rheumatic diseases.

Authors:  Songül Çildağ; Yasemin Kara; Taşkın Şentürk
Journal:  Eur J Rheumatol       Date:  2017-11-02

10.  Interactions Between Genome-Wide Genetic Factors and Smoking Influencing Risk of Systemic Lupus Erythematosus.

Authors:  Jing Cui; Soumya Raychaudhuri; Elizabeth W Karlson; Cameron Speyer; Susan Malspeis; Hongshu Guan; Jeffrey A Sparks; Hongru Ni; Xinyi Liu; Emma Stevens; Jessica N Williams; Emma E Davenport; Rachel Knevel; Karen H Costenbader
Journal:  Arthritis Rheumatol       Date:  2020-09-23       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.